logo

For the Inventor, By the Inventor

Frankfurt, Germany

Jochen Goerlitzer

This inventor holds 23 USPTO granted patents and 1 published patent application and 14 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Sanofi, Sanofi-Aventis. Active years: 2006-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jochen Goerlitzer. Retrieved from https://idiyas.com/inventor/jochen-goerlitzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 30.4

 

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal12 out of 1,857 
 
Sanofi-A Ventis Deutschland Gmbh
 patents
silverMedal6 out of 1,549 
 
Sanofi
 patents
bronzeMedal4 out of 390 
 
Sanofi-Aventis
 patents
4. 3 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
5. 1 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2006-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Thienomethylpiperazine
Isoquinoline Derivatives
P2Y12 Antagonists
Coagulation Factor IXa
PPAR Delta Modulators
Oxadiazol-2-ones
Cycloalkylamine
Arylcycloalkyl
Pharmaceuticals
Acidic Derivatives
Carboxylic Acids
Neurological Disease
23 patents (USPTO):Explore Patents
1. 9776991 - Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase (2017-10-03),
2. 8772492 - Substituted isoquinoline and isoquinolinone derivatives (2014-07-08),
3. 8748614 - Substituted isoquinoline and isoquinolinone derivatives (2014-06-10),
4. 8710077 - Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives (2014-04-29),
5. 8598179 - Pyrazole-carboxamide derivatives as P2Y12 antagonists (2013-12-03),
6. 8263621 - Tartrate derivatives for use as coagulation factor IXa inhibitors (2012-09-11),
7. 8097758 - Isoserine derivatives for use as coagulation factor IXa inhibitors (2012-01-17),
8. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),
9. 7872034 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2011-01-18),
10. 7872032 - 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof (2011-01-18),
11. 7713988 - 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments (2010-05-11),
12. 7709509 - Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists (2010-05-04),
13. 7709494 - 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments (2010-05-04),
14. 7709490 - 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments (2010-05-04),
15. 7638539 - 1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease (2009-12-29),

Title: Innovations and Contributions of Jochen Goerlitzer

Introduction

Jochen Goerlitzer is a prominent inventor based in Frankfurt am Main, Germany. With an impressive portfolio of 23 patents, he has made significant contributions to the fields of pharmacology and medicinal chemistry.

Latest Patents

Among his latest innovations, Jochen developed thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase. This invention relates to compounds of a specific formula that demonstrate pharmacologically active properties, particularly in the therapy and prevention of various medical conditions, including renal failure, diabetic nephropathy, and cardiovascular diseases. Furthermore, it encompasses the processes for preparing these compounds and their integration as active ingredients in pharmaceuticals.

Additionally, Jochen has worked on substituted isoquinoline and isoquinolinone derivatives, which are designed to treat diseases associated with Rho-kinase and related phosphorylation processes. These compounds hold potential for therapeutic applications and are included in compositions aimed at medical use.

Career Highlights

Jochen's professional journey includes significant roles at well-regarded pharmaceutical companies, such as Sanofi and Sanofi-Aventis Deutschland GmbH. These experiences have enriched his expertise in drug development and innovation.

Collaborations

Throughout his career, Jochen has collaborated with notable colleagues, including Stefanie Keil and Wolfgang Wendler. These collaborations have likely contributed to the advancement of their research and the development of innovative therapeutic solutions.

Conclusion

Jochen Goerlitzer stands out as an influential figure in the field of pharmacology, supported by his extensive patent portfolio and collaborative efforts. His work continues to shape the future of medical treatments and provides hope for various health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…